Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Conmed ( (CNMD) ) has issued an announcement.
On January 27, 2025, Andrew Moller began his role as Vice President, Corporate Controller at CONMED Corporation, a company involved in the medical technology industry. By April 1, 2025, Moller was appointed as the Principal Accounting Officer, succeeding Todd W. Garner in this role. Additionally, Kimberly A. Lockwood was promoted to Senior Director of Financial Reporting. Moller brings extensive experience from his previous roles at Smith & Nephew plc and Stanley Black & Decker, enhancing CONMED’s leadership team.
More about Conmed
YTD Price Performance: -11.45%
Average Trading Volume: 486,167
Technical Sentiment Signal: Buy
Current Market Cap: $1.87B
For an in-depth examination of CNMD stock, go to TipRanks’ Stock Analysis page.